Levack, Russell C. http://orcid.org/0000-0003-1992-1961
Newell, Krista L. http://orcid.org/0000-0002-2152-2073
Cabrera-Martinez, Berenice
Cox, Justin http://orcid.org/0000-0003-3095-1512
Perl, Andras
Bastacky, Sheldon I.
Winslow, Gary M. http://orcid.org/0000-0002-7051-4299
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI114545-05)
Article History
Received: 24 December 2020
Accepted: 20 December 2021
First Online: 21 January 2022
Competing interests
: The authors declare the following competing interests: G.M.W. and R.C.L. are inventors listed on a patent pending for the use of A<sub>2A</sub> receptor agonists in the therapeutic depletion of CD11c<sup>+</sup>T-bet<sup>+</sup> B cells in diseases mediated by these B cells. Applicant: SUNY Research Foundation, Application Serial Number: PCT/US2019/045624. The remaining authors declare no competing interests.